Arthur Cohn and Irina Macovei discuss the complexities of life sciences distribution agreements, covering key topics like the importance of customization based on regulatory differences between countries, provisions including exclusivity, liability, pricing, and termination clauses, and the need for careful consideration and adaptation to ensure compliance and effectiveness across various jurisdictions.